Home Tools
Log in
Cart

Search Result

Search Results for " acromegaly "

Targets

9

Compounds

1

Recombinant Proteins

Cat No. Product Name Synonyms Targets
T2584 Octreotide SMS 201-995 Somatostatin
Octreotide (SMS 201-995) is a potent inhibitor of growth hormone, glucagon, and insulin.
T11798 L-692429 MK-0751 GHSR , GPCR19
L-692429 (MK-0751) is a potent nonpeptidyl growth hormone secretagogue (GHS) agonist, a benzolactam derivative, which reverses the inhibition of GH secretion by glucocorticoids.L-692429 has a high affinity for the G prot...
T39262L BIM-23190 aceate Somatostatin
BIM-23190 aceate, a somatostatin analog, a selective agonist of SSTR2 and SSTR5. BIM-23190 can be used in cancer and acromegaly studies.
T9692 Paltusotine Somatostatin
Paltusotine is a nonpeptide, small molecule somatostatin type 2 (SST2) receptor agonist with high oral bioavailability. Paltusotine maintains GH and IGF-1 levels in acromegaly patients
T20534 Lanreotide BIM 23014,Somatulin,Lanreotide Autogel,Somatuline,Ipstyl
Lanreotide, a somatostatin analogue, suppresses GH/IGF-I hypersecretion in acromegaly patients. It also used to manage neuroendocrine tumours.
T39262 BIM-23190
BIM-23190 is a somatostatin analog that acts as a selective agonist for SSTR2 and SSTR5 receptors. It displays potency with K i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 finds utility in ...
T37109 BIM-23190 hydrochloride
BIM-23190 hydrochloride, a selective agonist for somatostatin receptors SSTR2 and SSTR5 with Ki values of 0.34 nM and 11.1 nM respectively, is a somatostatin analog utilized in research on cancer and acromegaly[1][3].
T75157 Cimdelirsen
Cimdelirsen, a novel ligand-conjugated, hepatic-targeted antisense oligonucleotide under investigation, aims to diminish growth hormone receptor (GHr) synthesis. This inhibits the harmful effects of growth hormone (GH) h...
T75157L Cimdelirsen sodium
Cimdelirsen sodium is a novel, ligand-conjugated, hepatic-targeted investigative antisense oligonucleotide designed to reduce growth hormone receptor synthesis.

Recombinant Proteins

Cat No. Product Name Species Expression System
TMPK-00806 GHR/Growth Hormone R Protein, Human, Recombinant (His) Human HEK293
Pegvisomant, a growth hormone receptor (GHR) antagonist, is a well-known drug that was designed to treat acromegaly. However, recent studies have indicated that the GHR is a "moonlighting" protein that may exhibit dual f...
TargetMol